Skip to main content

Advertisement

Table 1 Summary of patient data

From: Safety of MR-guided focused ultrasound treatment of pedunculated subserosal uterine leiomyomas

Patient number Age (years) Treated pedunculated leiomyoma Stalk Number of leiomyomas treated Complications Alternative treatment Follow-up (months)
   Largest diameter (cm) Volume (cm3) NPV (cm3) NPV/LV Diameter (cm) SD/LD Total Pedunculated    
1 47 10.6 477 122 0.26 5.1 0.48 4 1 No No 36
2 39 8 170 73 0.43 3.7 0.46 4 3 No Yes 3
3 37 13 351 60 0.17 3.5 0.27 8 1 No Yes 45
4 46 10.4 370 102 0.28 2.7 0.26 3 1 No Yes 46
5 40 5.9 83 15 0.19 1.8 0.31 1 1 No No 26
6 33 11 478 196 0.41 4.8 0.44 2 1 No Yes 16
7 52 11.5 522 218 0.42 3.9 0.34 1 1 No No 36
8 41 6.9 105 16 0.16 3.3 0.48 3 1 Yes No 14
9 51 11.7 645 523 0.81 3.6 0.31 1 1 Yes No 15
10 35 11 482 215 0.45 3.9 0.35 1 1 No No 14
11 47 9.9 376 23 0.06 1.6 0.16 2 1 No No 4
Average 42.5 10 369 142 0.33 3.4 0.36 2.7 1.2 - - 23.2
Minimum 33 5.9 83 15 0.06 1.6 0.16 1 1 - - 3
Maximum 52 13 645 523 0.81 5.1 0.48 8 3 - - 46
  1. Abbreviations: cm, centimeters; cm3, cubic centimeters; NPV, non-perfused volume; LV, leiomyoma volume; SD, stalk diameter; LD, leiomyoma diameter. Age is at the time of FUS treatment. Follow-up is the duration of clinical follow-up that was available.